E-viri
Odprti dostop
-
Vitanza, Nicholas A; Wilson, Ashley L; Huang, Wenjun; Seidel, Kristy; Brown, Christopher; Gustafson, Joshua A; Yokoyama, Jason K; Johnson, Adam J; Baxter, Blake A; Koning, Ryan W; Reid, Aquene N; Meechan, Michael; Biery, Matthew C; Myers, Carrie; Rawlings-Rhea, Stephanie D; Albert, Catherine M; Browd, Samuel R; Hauptman, Jason S; Lee, Amy; Ojemann, Jeffrey G; Berens, Michael E; Dun, Matthew D; Foster, Jessica B; Crotty, Erin E; Leary, Sarah E S; Cole, Bonnie L; Perez, Francisco A; Wright, Jason N; Orentas, Rimas J; Chour, Tony; Newell, Evan W; Whiteaker, Jeffrey R; Zhao, Lei; Paulovich, Amanda G; Pinto, Navin; Gust, Juliane; Gardner, Rebecca A; Jensen, Michael C; Park, Julie R
Cancer discovery, 01/2023, Letnik: 13, Številka: 1Journal Article
Diffuse intrinsic pontine glioma (DIPG) remains a fatal brainstem tumor demanding innovative therapies. As B7-H3 (CD276) is expressed on central nervous system (CNS) tumors, we designed B7-H3-specific chimeric antigen receptor (CAR) T cells, confirmed their preclinical efficacy, and opened BrainChild-03 (NCT04185038), a first-in-human phase I trial administering repeated locoregional B7-H3 CAR T cells to children with recurrent/refractory CNS tumors and DIPG. Here, we report the results of the first three evaluable patients with DIPG (including two who enrolled after progression), who received 40 infusions with no dose-limiting toxicities. One patient had sustained clinical and radiographic improvement through 12 months on study. Patients exhibited correlative evidence of local immune activation and persistent cerebrospinal fluid (CSF) B7-H3 CAR T cells. Targeted mass spectrometry of CSF biospecimens revealed modulation of B7-H3 and critical immune analytes (CD14, CD163, CSF-1, CXCL13, and VCAM-1). Our data suggest the feasibility of repeated intracranial B7-H3 CAR T-cell dosing and that intracranial delivery may induce local immune activation. This is the first report of repeatedly dosed intracranial B7-H3 CAR T cells for patients with DIPG and includes preliminary tolerability, the detection of CAR T cells in the CSF, CSF cytokine elevations supporting locoregional immune activation, and the feasibility of serial mass spectrometry from both serum and CSF. This article is highlighted in the In This Issue feature, p. 1.
Avtor
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.